Quantcast

Latest Ulcerative colitis Stories

2014-10-29 08:32:05

FREIBURG and HEIDELBERG, Germany, October 29, 2014 /PRNewswire/ -- Positive FDA feedback on the protocol for the US Phase III trial with LT-02, a key element of the product's global development program Lipid Therapeutics today announces that its European co-development partner Dr. Falk Pharma GmbH has enrolled the first patients into a pivotal Phase III trial with LT-02, a novel barrier function therapy for mild-moderately active ulcerative...

2014-10-27 20:22:39

LA JOLLA, Calif., and JUPITER, Fla., Oct. 27, 2014 /PRNewswire-USNewswire/ -- Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute (TSRI). According to results released today from a Phase 2 study of 199 patients with active, moderate to severe disease, the drug candidate RPC1063 has potential to significantly improve the treatment paradigm for ulcerative colitis patients....

2014-10-27 08:28:51

"Get Your Full Course" addresses diet and nutritional considerations related to inflammatory bowel diseases and highlights Sunny's personal story of living with ulcerative colitis HORSHAM, Pa., Oct. 27, 2014 /PRNewswire/ -- Janssen Biotech, Inc. and the Crohn's & Colitis Foundation of America (CCFA) announced today the launch of Get Your Full Course, an educational campaign designed to provide resources for people living with inflammatory bowel diseases (IBD) on the paired role...

2014-10-22 04:22:24

Immune Pharmaceuticals Recently Initiated Phase II Clinical Trial in Ulcerative Colitis CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Oct. 22, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP; "Immune" or "the Company") announces that Dr. Tomer Adar, a gastro-enterologist at the Institute for Digestive Diseases at Shaare Zedek Medical Center, Israel, is presenting today at the United European Gastro-Enterology week in Vienna, Austria an abstract entitled "The...

2014-10-13 12:27:24

U.S. and international grantees will receive funds to support innovative, collaborative approaches to investigate potential new treatments and therapies for Inflammatory Bowel Disease. OAKLAND, Calif., Oct. 13, 2014 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today that it will grant $2.2 million to scientists to conduct Inflammatory Bowel Disease (IBD) research. The Rainin Foundation offers support for cutting-edge projects that typically are not eligible for funding...

2014-10-08 08:26:55

DUBLIN, Oct. 8, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Crohn's Disease Drug Market and Pipeline Analysis" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Under the umbrella of inflammatory bowel diseases, Crohn's disease and ulcerative colitis are two most common disorders. Though both these disorders have similar symptoms, the difference arises in the areas affected in the gastrointestinal tract (GI tract). The Crohn's...

2014-10-07 12:31:27

PREPOPIK a prescription bowel prep for colonoscopy offers the lowest volume of active prep solution -- only 10 ounces PARSIPPANY, N.J., Oct. 7, 2014 /PRNewswire/ -- Colonoscopy is an important and widely used screening tool for colorectal cancer, but for many patients the bowel-preparation process is more uncomfortable than the procedure itself. To offer an alternative choice in bowel preparation, Ferring Pharmaceuticals Inc. will introduce a new cranberry flavor option of PREPOPIK...

2014-09-18 04:21:05

Company Recently Initiated Phase II in Bullous Pemphigoid CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Sept. 18, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC). Dr. Daniel Teper, Chairman and CEO of Immune comments: "Bertilimumab is...

2014-08-21 08:28:09

Sigma-Tau Pharmaceuticals Goal is to Broaden Consumer Awareness of VSL#3 and Meet Consumers at the Shelf; Pharmacy Cards Rolling Out At Stores Nationwide GAITHERSBURG, Md., Aug. 21, 2014 /PRNewswire/ -- Consumers have gotten used to seeing shelf cards in place of full product packages in certain categories of products, such as cold and flu, when either price or ingredients are deemed an issue for the store. Now, in an effort to offer consumers a different type of probiotic, one that...

2014-08-20 16:23:24

NEW YORK, Aug. 20, 2014 /PRNewswire/ -- Acclaimed Actress Amy Brenneman may play a silenced police chief's wife in her new role on "The Leftovers," but she generously lends her voice to help raise awareness for Crohn's disease and ulcerative colitis in a newly refreshed public service awareness campaign. To view the multimedia assets associated with this release, please click...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.